Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Lesionnaire's syndrome"

Dennis Velakoulis1, Christos Pantelis, Mark Walterfang

  • 1Melbourne Neuropsychiatry Centre, Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3050, Australia. dennis.velakoulis@mh.org.au

The Medical Journal of Australia
|December 13, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia.

Schizophrenia (Heidelberg, Germany)·2024
Same author

Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia and levels of glutamatergic metabolites.

Schizophrenia (Heidelberg, Germany)·2024
Same author

Cortical similarities in psychiatric and mood disorders identified in federated VBM analysis via COINSTAC.

Patterns (New York, N.Y.)·2024
Same author

Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode Psychosis.

Biological psychiatry·2024
Same author

Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI Study.

Schizophrenia bulletin·2024
Same author

Plasma neurofilament light protein is differentially associated with age in individuals with treatment-resistant schizophrenia and bipolar affective disorder compared to controls.

Psychiatry research·2024